MedPath

Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia

Phase 4
Recruiting
Conditions
Toxemia of Pregnancy
10010273
Registration Number
NL-OMON50177
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
44
Inclusion Criteria

Women (>=18 years) with a singleton pregnancy diagnosed with PE with a
gestational age between >= 20 weeks and <35 weeks admitted to the obstetric
department who give written informed consent, will be included.

Exclusion Criteria

- Multiple pregnancies , - Not willing to give written informed consent., -
Other reasons than (suspected) PE requiring hospitalization, - The use of PPI
at time of randomization, - Contraindications or hypersensitivity to PPI use, -
The use of medication affected by PPI , - Fetal death at time of inclusion, -
Signs of fetal distress at time of inclusion, - Expected delivery of <= 2 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath